Adjuvant Chemotherapy Is Associated with Improved Survival for Stage III Colon Cancer When Initiated Beyond 8 Weeks.
Fasih Ali AhmedVictoria S WuHanna KakishLuke RothermelSharon L SteinEmily SteinhagenRichard HoehnPublished in: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract (2023)
Receipt of AC for stage III colon cancer may be affected by surgical complications or otherwise prolonged recovery. Timely and even delayed AC (>8 weeks) are both associated with improved overall survival. These findings highlight the importance of delivering guideline-based systemic therapies, even after complicated surgical recovery.